Reporting Manager
Squadron Capital Management LLC
Symbol
LPCN
Shares outstanding
5,555,556 shares
Disclosed Ownership
500,000 shares
Ownership
9%
Form type
SCHEDULE 13G
Filing time
23 Dec 2025, 15:49:40 UTC
Date of event
18 Dec 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"Squadron Capital Management LLC disclosed 9% ownership in Lipocine Inc. Common Stock, par value $0.0001 per share (LPCN) on 18 Dec 2025."

Quick Takeaways

  • Squadron Capital Management LLC filed SCHEDULE 13G for Lipocine Inc. Common Stock, par value $0.0001 per share (LPCN).
  • Disclosed ownership: 9%.
  • Date of event: 18 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 23 Dec 2025, 15:49.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Squadron Master Fund LP 8% 444,632 0 444,632 /s/ Matthew Sesterhenn Partner, Squadron Partners LLC, its General Partner
Squadron Capital Management LLC 9% 500,000 0 500,000 /s/ Matthew Sesterhenn Partner
Matthew Sesterhenn 9% 500,000 0 500,000 /s/ Matthew Sesterhenn Matthew Sesterhenn
William Blank 9% 500,000 0 500,000 /s/ William Blank William Blank